Trial
NCT00633087
A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rutgers, The State University of New Jersey
Collaborators
United States Department of Defense
Condition
Prostate Cancer
Intervention
2-deoxyglucose
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-22